Marrow Stem Cell Gene is Identified
Posted on: Monday, 14 April 2008, 15:00 CDT
U.S. scientists say they have identified a gene responsible for the division and movement of marrow-derived, blood-forming stem cells.
The researchers at the Joslin Diabetes Center said their discovery could have major implications for the future of bone marrow and blood cell transplantation.
Every year, some 45,000 people undergo bone marrow or peripheral blood progenitor cell transplantation for treatment of a variety of diseases, including leukemia, lymphoma and immunodeficiency. The Joslin scientists say blood cell transplantation might also one day help people with diabetes better tolerate islet cell transplants without the need for prolonged use of powerful immunosuppressive drugs.
In studying mice that lack the transcription factor early growth response gene, or EGR-1, a Joslin team led by Amy Wagers, found hematopoietic stem cells in the marrow of the mice divided about twice as often as stem cells in mice with the gene. Mice lacking EGR-1 also had higher numbers of such stem cells circulating in their blood.
The study is the first to identify EGR-1 as a regulator of hematopoietic stem cell migration and proliferation.
The research is reported in the journal Cell Stem Cell.
Source: United Press International
Related Articles
- Scientists Successfully Reprogram Blood Cells
- Cutting The Fat Boosts Blood Recovery After Marrow Transplant
- StemCyte, Inc. Reaches 1,000th Cord Blood Stem Cell Shipment for Transplant Milestone
- Sickle Cell Bone Marrow Transplant Best
- New Publication of Phase 2 Data Shows Maribavir Markedly Reduced the Rate of Cytomegalovirus Infection and Disease in Bone Marrow Transplant Patients
- Study Assays Marrow Transplant Troubles
- Bone Marrow Transplantation Nephropathy After an Intensified Conditioning Regimen With Radioimmunotherapy and Allogeneic Stem Cell Transplantation
- Chemokine Therapeutics to Present Phase 1 Clinical Data at the 2006 Blood and Bone Marrow Transplantation Conference
- European Commission Approves Kepivance(TM) (Palifermin) for Oral Mucositis in Cancer Patients Undergoing Blood and Bone Marrow Transplant
- Marrow Transplant Technique May Help Blood Cancer Patients
User Comments (0)

RSS Feeds